Palliativedrugs.com announce the release of the Palliative Care Formulary Canadian edition.

11th August 2010

Palliativedrugs.com is proud to announce the release of the Canadian edition of their highly acclaimed Palliative Care Formulary, now available exclusively through the Canadian Hospice Palliative Care Association.

Since gaining recognition as a medical field in the 1970s, palliative care has expanded rapidly and will maintain growth as the Canadian population ages. The new Palliative Care Formulary, Canadian Edition will make a significant contribution toward the provision of high quality palliative care. Its 617 pages contain the most up-to-date, comprehensive information on medications used in hospice and palliative care, including dosage recommendations, pharmacokinetic data and off-label usage. Revised and updated from the UK third edition and the associated website, www.palliativedrugs.com, the Canadian Edition has been adapted to meet the specific requirements of the Canadian marketplace. Already established as a standard text, over 40,000 copies of the UK and USA editions of the Palliative Care Formulary have been sold worldwide.

For over 10 years, www.palliativedrugs.com has been serving palliative care professionals as a source of free information on medicine and care. With over 13,000 members worldwide (2,000 in North America), www.palliativedrugs.com also offers its 5,000 monthly visitors a community of experienced professionals who answer queries and discuss issues on its bulletin board.

The new Canadian Edition is exclusively distributed by the Canadian Hospice Palliative Care Association, www.chpca.net, through their marketplace at www.market-marche.chpca.net. CHPCA members are eligible for a discount on the Canadian Edition.

The editorial board of Palliative Care Formulary, Canadian Edition ISBN 9780955254741:

Dr. Robert Twycross, one of the founders of modern palliative medicine, has pioneered the field since the 1970s. He has taught in 50 countries, served as the Head of the WHO’s Collaborating Centre for Palliative Care, the Academic Director for the Oxford International Centre for Palliative Care, and was the Macmillan Clinical Reader in Palliative Medicine at Oxford University. Dr. Twycross has received numerous lifetime achievement awards from organizations across the world, and written nearly 300 articles, chapters, editorials and books.

Dr. Andrew Wilcock has been active in the field of palliative care since 1991, and is the Macmillan Clinical Reader in Palliative Medicine and Medical Oncology at Nottingham University and Consultant Physician at the Hayward House Macmillan Specialist Palliative Care Unit at Nottingham University Hospitals NHS Trust. In 2000 he co-founded the website, www.palliativedrugs.com with Dr. Twycross.

Dr. Mervyn Dean has over ten years of experience in palliative care medicine. Educated in Britain, he has lived and worked in Canada since 2000, and is currently the Medical Director of Palliative Care at Western Memorial Hospital, Newfoundland.

Bruce Kennedy, BSc (Pharm) is a Clinical Pharmacist specializing in Palliative Care at Fraser Health, where he provides education and support to doctors, nurses and other healthcare personnel dealing palliative issues. He has lived and worked in British Columbia for over 30 years.

For review copies, feature information or interview contact details, please contact Joe Kreuser at joe.kreuser@palliativedrugs.com.

To order copies of the Palliative Care Formulary, Canadian Edition ISBN 9780955254741 in North America, go directly to www.market-marche.chpca.net.

For orders from all other countries please e-mail hq@palliativedrugs.com.

Click to download press release (PDF)